Find Articles in:
All
Business
Reference
Technology
News
Lifestyle

Lexapro cleared for new use by FDA

Pharma Marketletter, January, 2004

The US Food and Drug Administration has approved the use of Forest's Lexapro (escitalopram) for the treatment of generalized anxiety disorder.

The decision was based on three randomized, double-blind, placebo-controlled eight-week studies involving around 850 patients aged 18-80 years. Subjects receiving Lexapro ...

 

BNET TalkbackShare your ideas and expertise on this topic

The following tags are supported in BNET comments:
<b></b> <i></i> <u></u> <pre></pre>

Leave a Reply

  1. You are currently a guest | Login?
advertisement
Go
advertisement
  • Click Here
  • Click Here